Snowball logo
logo
BIOR_logo

Bio-Rad Laborat ORD SHS CL A

₽3,333.00₽0.00  (0%)
Estimate
P/E
0.2
EPS
2,193.546
Beta
0.038
Growth
Revenue, YoY
0.55%
Net income, YoY
17.61%
FCF, YoY
-5.19%
Forecast
P/E (FWD)
39
EPS (FWD)
9.747
About the company
Ticker
BIO-RM
ISIN
US0905722072
Country
Other
Sector (GICS)
Healthcare
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Frequently asked questions

What sector does Bio-Rad Laborat ORD SHS CL A (BIO-RM) operate in?

Bio-Rad Laborat ORD SHS CL A belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Bio-Rad Laborat ORD SHS CL A (BIO-RM) current stock price?

As of the latest data, Bio-Rad Laborat ORD SHS CL A stock price is RUB 3,333.00, with a previous close of RUB 3,333.00.

What is Bio-Rad Laborat ORD SHS CL A (BIO-RM) current market capitalization?

Bio-Rad Laborat ORD SHS CL A market cap is approximately 8.25 billion.

What is Bio-Rad Laborat ORD SHS CL A (BIO-RM) Earnings Per Share (EPS)?

The trailing EPS is RUB 2,193.55, and the forward EPS is RUB 9.75.

What is Bio-Rad Laborat ORD SHS CL A (BIO-RM) Price-to-Earnings (P/E) ratio?

Bio-Rad Laborat ORD SHS CL A current P/E ratio is 0.17, with a forward P/E of 38.99.

What is Bio-Rad Laborat ORD SHS CL A (BIO-RM) EBITDA?

Bio-Rad Laborat ORD SHS CL A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 42.66 billion.

Does Bio-Rad Laborat ORD SHS CL A (BIO-RM) pay dividends?

No. Bio-Rad Laborat ORD SHS CL A does not pay a dividend.

How did Bio-Rad Laborat ORD SHS CL A (BIO-RM) perform in its most recent earnings report?

In the last report (June 30, 2026), Bio-Rad Laborat ORD SHS CL A posted an EPS surprise of 11.97% and a revenue surprise of 8,110.73%.

When is Bio-Rad Laborat ORD SHS CL A (BIO-RM) next earnings report?

Bio-Rad Laborat ORD SHS CL A is expected to release its next earnings report on September 30, 2026.

What is Bio-Rad Laborat ORD SHS CL A (BIO-RM) beta (volatility) score?

Bio-Rad Laborat ORD SHS CL A has a beta of 0.038, indicating lower volatility than the overall market.